NSEUpdates3 Jul 2026 · 3 Jul 2026, 03:48 pm
Updates
Shilpa Medicare Limited · SHILPAMED
✦ AI SummaryResults
Shilpa Medicare Limited has announced its audited financial results for the fourth quarter and financial year ended March 31, 2026, along with the appointment of cost auditors and internal auditors, and other corporate updates.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shilpa Medicare Limited has informed the Exchange regarding 'Machine Readable copy of Financial Results '.
Attachments (1)
📄pdf
Download →
SHILPAMED_03072026154440_SML_outcome.pdf
View document text
L Shi/pa Medicare Limited
I Innovating for Corporate & Admin Office:
. . affordable healthcare "Shilpa House",# 12 -6-214/A-1, Hyderabad Road,
Raichur 584 135, Karnataka, India
Tel: +91-8532-238704, Fax: +91-8532-238876
Email: info@vbshilpa.com, Web: www.vbshilpa.com
CIN: L85110KA1987PLC008739
Date: 22May 2026
Corporate Relationship Department National Stock Exchange of India Limited
BSE Limited Exchange Plaza, 5" Floor,
Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block
Dalal Street, Fort, Bandra Kurla Complex, Bandra (E)
Mumbai-400 001 Mumbai-400 051
Scrip Code: BSE - 530549/ Stock Symbol: NSE SHILPAMED
Dear Sir/ Ma'am,
Sub: Outcome of the Board Meeting
Ref: Regulation 30,33 & 43 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015
With reference to the captioned subject, we hereby wish to inform you that the Board at its meeting held
today, i.e., on 22 May 2026, which commenced at 12.25 P.M and concluded at 2.4 0 P.M has inter
alia considered and approved the following:
1) Financials:
(a) Audited financial statements (Standalone & Consolidated) for the financial year ended 31 March
2026 together with statement of assets and liabilities, statement of cash flows along with the
Auditors' Report with unmodified opinion.
(b) Audited financial results (Standalone & Consolidated) for the Fourth quarter and financial year
ended31 March 2026.
(c) A declaration to the effect that the Auditors have given an unmodified opinion on the Audited
financial statements (Standalone & Consolidated) for the financial year ended 31 March 2026.
2) The Board has recommended a final dividend of Re. 0.60/- (60%) per equity share of face value of
Re. 1/- each for FY2025-26. The final dividend, if approved by the members atthe ensuing Annual
General Meeting, shall be paid within the statutory timelines prescribed under applicable laws.
3) Appointment of M/s. V.J.Talati & Co., Cost Accountants as Cost Auditors of the Company for the
FY 2026-27.
4) Appointment of M/s ANEJA ASSOClATES . as Internal Auditors of the Company for FY2026-
27. Details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 read with Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th
January 2026 are annexed herewith.
L Shi/pa Medicare Limited
I Innovating for Corporate & Admin Office:
. . affordable healthcare "Shilpa House",# 12 -6-214/A-1, Hyderabad Road,
Raichur 584 135, Karnataka, India
Tel: +91-8532-238704, Fax: +91-8532-238876
Email: info@vbshilpa.com, Web: www.vbshilpa.com
CIN: L85110KA1987PLC008739
5) Shifting of registered office from #12-6-214/A1, Hyderabad Road, Raichur, Karnataka, India
584135 (State of Karnataka) to State of Maharashtra and to alter the situation clause of the
memorandum of association, subject to the approval of members (by way of Postal Ballot) and
other authorities, while retaining the Statutory books and registers at #12-6-214/A1, Hyderabad
Road, Raichur, Karnataka, India 584135.
6) Notice of Postal Ballot for Shifting of registered office from state of Karnataka to State of
Maharashtra and to alter the situation clause of the memorandum of association, subject to the
approval of members.
7) Appointment of Mr. Santosh Kumar Gunemoni (M. No: A60103) Practicing Company Secretary,
VCAN & Associatesto act as Scrutinizer for the process of Postal Ballot.
8) Shilpa Pharma Lifesciences Limited ("SPL") , Shilpa Biologicals Pvt Ltd ("SBPL"), Shilpa Biocare Pvt
Ltd ("Biocare") - wholly owned subsidiaries of Shilpa Medicare Limited, to make an equity
investment of 28% in Neo Green Power Project Private Limited. Details as required under SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Master Circular No.
HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026 are annexed herewith.
9) Shifting of registered office of following Wholly Owned Subsidiaries:
a. Shilpa Pharma Lifesciences Limited
b. Shilpa Biologicals Private Limited
c. Shilpa Biocare Private Limited
d. SampraHoldings Private Limited (formerly knownas Vegil Labs Private Limited)
from the State of Karnataka to State of Maharashtra.
This document ismade available on the website of the Company at https://www.vbshilpa.com/financial-
results.php.
For Shilpa Medicare Limited,
u 1wary
TD ii wgi at ,a yll y signed by Ritu
Datec2026.05.2214,47,45
+05'30'
Ritu Tiwary
Company Secretary & Compliance Officer
L Shi/pa Medicare Limited
I Innovating for Corporate & Admin Office:
. . affordable healthcare "Shilpa House",# 12 -6-214/A-1, Hyderabad Road,
Raichur 584 135, Karnataka, India
Tel: +91-8532-238704, Fax: +91-8532-238876
Email: info@vbshilpa.com, Web: www.vbshilpa.com
CIN: L85110KA1987PLC008739
Details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read
with Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026.
Appointment of Cost Auditor
1 Name M/s. V J Talati & Co
2 Reason for change viz., appointment, re- Appointment
appointment, resignation, removal, death or
otherwise
3 Date of Appointment/re-appointment/cessation May 22, 2026
& term of appointment or reappointment Term: for FY2026-2027
4 Brief Profile (in case of appointment) V. J. TALATI & CO. is a renowned firm
with extensive experience in cost
auditing and management consultancy
across various industries, including
Rubber, Textile, Chemicals,
Petrochemicals, Cement, Sugar, Steel,
and more. The firm specializes in cost
audit services, ensuring compliance
with statutory regulations, maintaining
records, and representing clients
before government authorities. They
also offer expertise in implementing
costing systems, stock-taking, and
valuation processes.
In addition, V. J. TALATI & CO provides
ERP consultancy, focusing on costing
and inventory modules. The firm excels
in management consultancy, assisting
clients with strategic decisions such as
"Make or Buy," job work orders, and
production continuity. With a strong
track record of delivering tailored
solutions, V. J. TALATI & CO.is a trusted
partner for optimizing cost structures
and improving operational efficiency.
5 Disclosure of relationship between directors (in Not Applicable
case of appointment of a director)
L Shi/pa Medicare Limited
I Innovating for Corporate & Admin Office:
. . affordable healthcare "Shilpa House",# 12 -6-214/A-1, Hyderabad Road,
Raichur 584 135, Karnataka, India
Tel: +91-8532-238704, Fax: +91-8532-238876
Email: info@vbshilpa.com, Web: www.vbshilpa.com
CIN: L85110KA1987PLC008739
Details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read
with Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026.
Appointment of Internal Auditor
Sl.no Details of event(s) that need to Information of such event(s)
be provided
1 Name M/s ANEJA ASSOClATES .
2 Reason for change viz.
appointment, reappointment, Appointment
resignation, cessation, removal,
death or otherwise
3 Date of appointment/ re- 22 May 2026
appointment/cessation (as Term:FY 2026-2027
applicable) & term of
appointment/re-appointment;
4 Brief profile (in case of M/s Aneja Assurance Pvt.Ltd, established in 1981, is a
appointment) governance, risk and compliance-focused professional
services firm with over 300 qualified staff and 40+ years of
experience. The firm specializes in integrated internal audits,
risk assessment, internal control design and information
systems audits, supported by proprietary methodologies
such as the Controls Effectiveness Index (CEI) and Robust
Controls Index (RCI). With global exposure across 30+
countries and a clientele of more than 250 leading
organizations in pharma, manufacturing, BFSI, engineering,
logistics, and services, Aneja Associates delivers transparent,
standards-aligned assurance reviews that enhance
governance processes and shareholder value.
5 Disclosure of relationships -NA
between directors (in case of
appointment of Director
L Shi/pa M
[Showing first 8,000 characters — download PDF for full document]